We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
Cap. Flow
+$445M
Cap. Flow %
0.87%
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.99B
2
MSFT icon
Microsoft
MSFT
+$522M
3
AMD icon
Advanced Micro Devices
AMD
+$511M
4
AMZN icon
Amazon
AMZN
+$318M
5
AAPL icon
Apple
AAPL
+$317M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$402M
2
MCD icon
McDonald's
MCD
+$375M
3
V icon
Visa
V
+$366M
4
META icon
Meta Platforms (Facebook)
META
+$319M
5
ADBE icon
Adobe
ADBE
+$272M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Healthcare 17.11%
3 Consumer Discretionary 13.31%
4 Financials 8%
5 Industrials 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRT icon
2151
Virtu Financial
VIRT
$4.86B
$253K ﹤0.01%
+14,822
New +$272K
ACCO icon
2152
Acco Brands
ACCO
$396M
$252K ﹤0.01%
+48,320
New +$243K
PTCT icon
2153
PTC Therapeutics
PTCT
$6.15B
$251K ﹤0.01%
+6,182
New +$302K
IMTX icon
2154
Immatics
IMTX
$1.33B
$250K ﹤0.01%
+21,700
New +$203K
NVEC icon
2155
NVE Corp
NVEC
$565M
$249K ﹤0.01%
2,558
-2,806
-52% -$243K
CAMP
2156
DELISTED
CalAmp Corp.
CAMP
$249K ﹤0.01%
10,193
-1,123
-10% -$54.5K
DYN icon
2157
Dyne Therapeutics
DYN
$4.99B
$248K ﹤0.01%
22,052
-110,292
-83% -$1.3M
BMTX.WS
2158
CALL
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$248K ﹤0.01%
83,195
-96,805
-54% -$18.3K
CBIO
2159
Crescent Biopharma
CBIO
$620M
$248K ﹤0.01%
1,424
-739
-34% -$124K
RKT icon
2160
Rocket Companies
RKT
$40.5B
$247K ﹤0.01%
27,600
-73,813
-73% -$642K
RXO icon
2161
RXO
RXO
$3.54B
$247K ﹤0.01%
10,879
-92,515
-89% -$1.86M
KIDS icon
2162
OrthoPediatrics
KIDS
$633M
$245K ﹤0.01%
+5,597
New +$258K
TOL icon
2163
Toll Brothers
TOL
$14.3B
$245K ﹤0.01%
+3,100
New +$208K
CLMB icon
2164
Climb Global Solutions
CLMB
$518M
$243K ﹤0.01%
+20,308
New +$247K
CCSI icon
2165
Consensus Cloud Solutions
CCSI
$677M
$242K ﹤0.01%
+7,797
New +$275K
ICPT
2166
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$241K ﹤0.01%
21,820
-91,501
-81% -$1.27M
SND icon
2167
Smart Sand
SND
$200M
$241K ﹤0.01%
147,066
-18,917
-11% -$31.2K
CANO.WS
2168
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$239K ﹤0.01%
171,658
-78,342
-31% -$19.6K
KBWP icon
2169
Invesco KBW Property & Casualty Insurance ETF
KBWP
$269M
$237K ﹤0.01%
2,900
-1,400
-33% -$116K
BCYC
2170
Bicycle Therapeutics
BCYC
$288M
$237K ﹤0.01%
9,271
-67,378
-88% -$1.56M
STAA icon
2171
STAAR Surgical
STAA
$1.24B
$237K ﹤0.01%
4,500
+600
+15% +$36.5K
VERA icon
2172
Vera Therapeutics
VERA
$2.18B
$236K ﹤0.01%
14,699
-30,087
-67% -$272K
SCYX icon
2173
SCYNEXIS
SCYX
$48.1M
$235K ﹤0.01%
+9,940
New +$232K
MVIS icon
2174
Microvision
MVIS
$86.6M
$234K ﹤0.01%
+3,410
New +$179K
CAL icon
2175
Caleres
CAL
$475M
$234K ﹤0.01%
+9,788
New +$219K

Similar funds

Marshall Wace's Q2 2023 Portfolio in Review

As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
  • Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
  • Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
  • Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
  • Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
  • Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.